The reiteration of an Underperform rating by a prominent analyst could negatively impact investor sentiment towards NYCB, potentially leading to a decrease in its stock price in the short term. The maintained price target of $6 suggests that the analyst sees limited upside potential for the stock, further contributing to negative sentiment.